Genprex, Inc. financial data

Symbol
GNPX on Nasdaq
Location
Austin, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -47.9%
Return On Equity -877 % -1.1%
Return On Assets -383 % -42.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,270,346 shares -73.3%
Common Stock, Shares, Outstanding 1,004,247 shares -81.7%
Entity Public Float 4,800,000 USD -90.1%
Common Stock, Value, Issued 1,004 USD -81.7%
Weighted Average Number of Shares Outstanding, Basic 760,502 shares +9.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10,070,832 USD -11.7%
General and Administrative Expense 6,261,424 USD -45%
Costs and Expenses 16,332,719 USD -28.4%
Operating Income (Loss) -16,332,719 USD +28.4%
Net Income (Loss) Attributable to Parent -16,769,203 USD +26.2%
Earnings Per Share, Basic 57 USD/shares +91.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1,103,315 USD -25.9%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 1,715,101 USD -10.6%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Other Assets, Noncurrent 1,847,412 USD -7.1%
Assets 3,562,513 USD -8.8%
Liabilities, Current 2,551,706 USD +13.8%
Liabilities 2,794,706 USD
Retained Earnings (Accumulated Deficit) -167,238,185 USD -11.1%
Stockholders' Equity Attributable to Parent 767,807 USD -53.9%
Liabilities and Equity 3,562,513 USD -8.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4,161,425 USD +21.5%
Net Cash Provided by (Used in) Financing Activities 6,028,103 USD -11.3%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 1,004,247 shares -81.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1,866,678 USD +26.2%
Deferred Tax Assets, Valuation Allowance 27,624,282 USD +17.9%
Deferred Tax Assets, Gross 28,161,687 USD +17.1%
Depreciation 463 USD -95.2%
Deferred Tax Assets, Operating Loss Carryforwards 20,215,112 USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 80,967,000 USD -49.2%
Additional Paid in Capital 168,004,988 USD +10.4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 928,276 USD -95.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%